• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

Pentagon accuses Alibaba, Baidu and BYD, three of China's biggest companies, of supporting the Chinese military

2

'We are rapidly running out of time': Watchdog sounds Social Security alarm after 22% cut confirmed for 2032

3

Costco CEO Ron Vachris rose from forklift driver to the C-suite without a college degree: ‘Don’t chase a title’ is the career advice that got him there

1

Pentagon accuses Alibaba, Baidu and BYD, three of China's biggest companies, of supporting the Chinese military

2

'We are rapidly running out of time': Watchdog sounds Social Security alarm after 22% cut confirmed for 2032

3

Costco CEO Ron Vachris rose from forklift driver to the C-suite without a college degree: ‘Don’t chase a title’ is the career advice that got him there
HealthBrainstorm Health

Brainstorm Health: Zombie Obamacare Repeal, GSK Lung Drug, Warby Parker Insurance

By
Clifton Leaf
Clifton Leaf
and
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Clifton Leaf
Clifton Leaf
and
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
September 19, 2017, 1:28 PM ET

Greetings, readers! This is Sy.

The Senate GOP may be just one vote shy of passing yet another version of Obamacare repeal. The legislation, sponsored by Sens. Lindsey Graham of South Carolina, Bill Cassidy of Louisiana, Dean Heller of Nevada, and Ron Johnson of Wisconsin, would fundamentally restructure not just Obamacare’s markets and mandated medical benefits, but the massive Medicaid program that serves the nation’s poor (and which was significantly expanded under the Affordable Care Act).

There’s no official Congressional Budget Office (CBO) analysis of the legislation yet and even a preliminary one won’t be available until next week. But the Senate has planned at least one hearing to debate the bill, and its sponsors are essentially arguing that a full CBO write-up won’t be necessary for Senators to make up their minds.

The Kaiser Family Foundation has a helpful comparison of what Graham-Cassidy would do relative to Obamacare. Some of the biggest changes would be to Medicaid, whose funding would be sharply rolled back under the bill and likely lead to tighter eligibility requirements, less generous benefits, or both. That would also mean expected coverage losses.

As of now, at least two GOP Senators are expected to oppose the legislation: Rand Paul of Kentucky, who doesn’t consider it a “true” Obamacare repeal, and Maine’s Susan Collins, who has been highly skeptical of Medicaid cuts. Just one more “nay” vote would kill the bill. But it’s unclear whether Alaska’s Lisa Murkowski or Arizona’s John McCain will vote, once again, to shelve a party-line health overhaul. Arizona’s governor has endorsed Graham-Cassidy while Alaska’s governor opposes it. And McCain has previously argued that wide-ranging health legislation should be done in “regular order” and through a bipartisan committee process.

Will that be enough to stop Obamacare repeal in its tracks yet again? Only time will tell.

Read on for the day’s news.

Sy Mukherjee
@the_sy_guy
sayak.mukherjee@fortune.com

DIGITAL HEALTH

BERG to offer AI-driven prostate cancer test under Defense Department partnership. Biopharma and health tech firm BERG announced Tuesday that its new prostate cancer test—which the company calls the first-ever commercial health product to be developed with the help of artificial intelligence—has been clinically validated. "We are proud of the clinical validation that we have achieved resulting from our collaboration with the DoD, and we are very excited about this new diagnostic test that has the potential to enhance the current approach to prostate cancer screening and detection," said BERG CEO Niven R. Narain in a statement. BERG combines the AI ambitions of tech startups with the structure of a pharmaceutical company housed under a single entity.

INDICATIONS

FDA approves GlaxoSmithKline's triple lung drug combo. The Food and Drug Administration on Monday approved British pharma giant GlaxoSmithKline's triple drug combination inhaler to treat chronic obstructive pulmonary disease (COPD), a degenerative lung condition that's the number three killer of people worldwide. The product, Trellegy Ellipta, will the first-of-its-kind combination treatment for COPD, and may reduce some patients' costs because they don't have to shell out separate co-pays for three different drugs that they already use. GSK has long been looking to make up for falling sales of its lung drug blockbuster Advair amid increased competition. (Reuters)

THE BIG PICTURE

Good news for hipsters: Warby Parker is going to start accepting insurance. In an exclusive, hip eyewear startup Warby Parker tells me that it will begin accepting UnitedHealthcare vision insurance in 2018. That means the company's frames could theoretically be purchased for as little as $30, the average co-pay for UnitedHealthcare vision plans, by about 20 million qualifying customers. (Fortune)

Walgreens finally cleared to buy nearly 2,000 Rite Aid stores. Walgreens says that it has received regulators' blessing to buy 1,932 Rite Aid stores, more about 250 less than it had originally planned to snap up. That will significantly expand Walgreens' already massive reach in the pharmacy chain industry. (Fortune)

REQUIRED READING

Hurricane Maria Is Now Officially a Category 5 Storm, by Reuters

Microsoft Just Announced a 'Mixed Reality' Event in October, by Jonathan Vanian

The New Obamacare Repeal Bill Could Lead to Single Payer, by Sally C. Pipes

Elon Musk's Angry Customer Twitter Thread Is a Gold Mine of Customer Service Advice, by Kirsten Korosec

Produced by Sy Mukherjee
@the_sy_guy
sayak.mukherjee@fortune.com

Find past coverage. Sign up for other Fortune newsletters.
About the Authors
By Clifton Leaf
See full bioRight Arrow Button Icon
By Sy Mukherjee
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

worm
HealthFood and drink
The pest that could devastate the American cattle industry was in Texas, but now it’s in New Mexico, too
By Jeffrey Collins and The Associated PressJune 9, 2026
24 hours ago
A man put a drink in front of Trump
HealthFood and drink
A Biden-era study told Americans to drink less alcohol. The Trump admin ‘sidelined’ the research facing pressure from the alcohol lobby
By Laura Ungar, Ali Swenson and The Associated PressJune 9, 2026
1 day ago
Kaged Pre-Workout Review (2026): Athlete Approved
HealthDietary Supplements
Kaged Pre-Workout Review (2026): Athlete Approved
By Christina SnyderJune 8, 2026
2 days ago
Liquid IV Review (2026): Our Personal Experience
HealthDietary Supplements
Liquid IV Review (2026): Our Personal Experience
By Christina SnyderJune 8, 2026
2 days ago
Biotics 8 Review (2026): Expert Tested
HealthDietary Supplements
Biotics 8 Review (2026): Expert Tested
By Emily PharesJune 8, 2026
2 days ago
Jacked Factory Authentic Whey Protein Review (2026)
HealthDietary Supplements
Jacked Factory Authentic Whey Protein Review (2026)
By Emily PharesJune 8, 2026
2 days ago

Most Popular

Pentagon accuses Alibaba, Baidu and BYD, three of China's biggest companies, of supporting the Chinese military
Asia
Pentagon accuses Alibaba, Baidu and BYD, three of China's biggest companies, of supporting the Chinese military
By Kate O'Keeffe and BloombergJune 8, 2026
2 days ago
'We are rapidly running out of time': Watchdog sounds Social Security alarm after 22% cut confirmed for 2032
Economy
'We are rapidly running out of time': Watchdog sounds Social Security alarm after 22% cut confirmed for 2032
By Nick LichtenbergJune 9, 2026
23 hours ago
Costco CEO Ron Vachris rose from forklift driver to the C-suite without a college degree: ‘Don’t chase a title’ is the career advice that got him there
Success
Costco CEO Ron Vachris rose from forklift driver to the C-suite without a college degree: ‘Don’t chase a title’ is the career advice that got him there
By Preston ForeJune 8, 2026
2 days ago
Current price of oil as of June 9, 2026
Personal Finance
Current price of oil as of June 9, 2026
By Joseph HostetlerJune 9, 2026
1 day ago
Current price of silver as of Tuesday, June 9, 2026
Personal Finance
Current price of silver as of Tuesday, June 9, 2026
By Joseph HostetlerJune 9, 2026
1 day ago
Wall Street dumped nearly $1 trillion in tech stocks by midday—then clawed it back and bought peanut butter and paint
Investing
Wall Street dumped nearly $1 trillion in tech stocks by midday—then clawed it back and bought peanut butter and paint
By Eva RoytburgJune 9, 2026
18 hours ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.